An update on glucocorticoid-induced osteoporosis

被引：58

作者：

Lane, NE ^{[1
]}

机构：

[1] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2001年 / 27卷 / 01期

关键词：

D O I：

10.1016/S0889-857X(05)70196-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Glucocorticoid-induced bone loss is the most common secondary cause of osteoporosis. This article reviews the epidemiology and pathophysiology of this problem. In addition, this article provides reasonable strategies for prevention and treatment.

引用

页码：235 / +

页数：20

共 118 条

[1]

Adachi JD, 1996, J RHEUMATOL, V23, P995

[2] Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].

Adachi, JD ;

Bensen, WG ;

Brown, J ;

Hanley, D ;

Hodsman, A ;

Josse, R ;

Kendler, DL ;

Lentle, B ;

Olszynski, W ;

SteMarie, LG ;

Tenenhouse, A ;

Chines, AA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387

[3]

ADACHI JD, IN PRESS ARTHRITIS R

[4] STEROID-INDUCED FRACTURES AND BONE LOSS IN PATIENTS WITH ASTHMA [J].

ADINOFF, AD ;

HOLLISTER, JR .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (05) :265-268

[5]

AFIFI AK, 1968, JOHNS HOPKINS MED J, V123, P158

[6] Treatment of glucocorticoid-induced growth suppression with growth hormone [J].

Allen, DB ;

Julius, JR ;

Breen, TJ ;

Attie, KM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2824-2829

[7] THE EFFECT OF GLUCOCORTICOIDS ON BONE MASS IN RHEUMATOID-ARTHRITIS PATIENTS - INFLUENCE OF MENOPAUSAL STATE [J].

ALS, OS ;

GOTFREDSEN, A ;

CHRISTIANSEN, C .

ARTHRITIS AND RHEUMATISM, 1985, 28 (04) :369-375

[8]

*AM COLL RHEUM, 1996, ARTHRITIS RHEUM, V39, P1291

[9]

Amin S, 1999, ARTHRITIS RHEUM-US, V42, P1740, DOI 10.1002/1529-0131(199908)42:8<1740::AID-ANR25>3.0.CO

[10]

2-E

← 1 2 3 4 5 6 7 8 9 10 →